Niraparib-bevacizumab-Dostarlimab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Niraparib-bevacizumab-Dostarlimab, covering 2021-07-15 to 2021-07-15. Get the full timeline:
Most recent: Clinical Trial Update: Trial Comparing Niraparib-bevacizumab-Dostarlimab and Niraparib-bevacizumab to Standard of Care in Recurrent Ovarian Cancer [Phase 3]